Long-acting insulin analogues versus NPH human insulin in type 2 diabetes: a meta-analysis.

@article{Monami2008LongactingIA,
  title={Long-acting insulin analogues versus NPH human insulin in type 2 diabetes: a meta-analysis.},
  author={Matteo Monami and Niccol̀o Marchionni and Edoardo Mannucci},
  journal={Diabetes research and clinical practice},
  year={2008},
  volume={81 2},
  pages={184-9}
}
BACKGROUND Long-acting insulin analogues, in comparison with NPH insulin, should warrant a greater reproducibility of absorption after subcutaneous injection, providing better metabolic control with reduced hypoglycaemic risk. Aim of the present meta-analysis is the assessment of differences with respect to HbA1c, incidence of hypoglycaemia, weight gain, between NPH human insulin and each long-acting analogue. METHODS All randomized controlled trials (RCTs) with a duration >12 weeks comparing… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 70 extracted citations

Similar Papers

Loading similar papers…